Schumer Urges FDA to Reconsider Postponement of 2016 E-Cigarette 'Deeming' Rule
Sen. Chuck Schumer, D-N.Y., in a letter urged the FDA to reconsider its delay of compliance deadlines for its rules deeming e-cigarettes, cigars and pipe tobacco part of the FDA’s regulatory purview, saying the ongoing postponement of enforcement is “devastating”…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
to “the public health of our national community.” The FDA in August announced the delay of premarket review compliance deadlines from 2017 and 2018, depending on the e-cigarette product and type of submission, to 2021 and 2022 (see 1708090020). “The FDA delayed crucial regulatory compliance deadlines for tobacco and e-cigarette products as outlined in the 2016 deeming rule” (see 1605050011), Schumer said in a statement. “When fully implemented it will provide consumers with additional health and safety warnings and require manufacturers to demonstrate that given products comply with health standards set by law.”